There is one scenario where gapper absence makes 100% sense. Right now, the talk of this deal is wait and get your dividend, (pretty far out right now) and then you'll receive diluted share power over in SAGA.
It's also a heckuva' maneuver to try and shake more ENZC shareholders out, cutting losses early. If the deal goes through, SAGA has less to effectively pay out,, and if the deal is a bust, or exits as a preplanned maneuver, ENZC has less shares to honor they'll be buying back for preferred legacy investors at a higher price.
Too many bad ways this could go, and mess around a lot of folks they hope panic and sell for something, even if it's a fraction back on their pennies.
I sure hope not, I plan on accumulating more and then putting even more feelers out on their staff, I'm at a lower total shareholdings than you and several others here, just 500K shares right now. Hope to get that up to at least one mil, BEOY. but I'd be lying if I said I didn't see the possible negative scenarios. The negative scenario details support the MM manipulations, the share price lock and lower, and the constant timeline changes that make no sense as their PR department scripts them, forgetting what and how they promised the news prior.
Our one worry, time-to-market has proven true, a half dozen big-pharma's now making serious mABS progress against Cancer(s), one says against Covid, another against HIV and Covid, and the others in lower organ treatments.
Which also makes this IPF-Immune testing in Africa sound ridiculous when Clone3 or another CloneX treatment needs full approval. On an encouraging note, the FDA yesterday afternoon, just approved a costly, and major medical program to complete development of a new treatment in the USA for a different company, simply because they got full approval from the EU, one week before.
GLTY!!
Terry
News 
Market Data 
Discover 
